Learn More
Invitrogen™ Human C19orf53 Control Fragment Recombinant Protein
Recombinant Protein
Brand: Invitrogen™ RP106973
Description
Highest antigen sequence indentity to the following orthologs: Mouse (77%), Rat (77%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-66292 (PA5-66292. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
May have a potential role in hypercalcemia of malignancy.
Specifications
Q9UNZ5 | |
Blocking Assay, Control | |
28974 | |
100 μL | |
C19orf53; chromosome 19 open reading frame 53; HSPC023; Leydig cell tumor 10 kDa protein homolog; LYDG10 | |
C19orf53 | |
Human | |
His-ABP-tag | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
≥5.0 mg/mL | |
1 M urea, PBS with no preservative; pH 7.4 | |
Human C19orf53 Control Fragment | |
RUO | |
C19orf53 | |
Unconjugated | |
Recombinant | |
GQRKFQAHKPAKSKTAAAASEKNRGPRKGGRVIAPRKARVVQQQ | |
E. coli | |
>80% by SDS-PAGE and Coomassie blue staining |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.